SCHEMBL2902229

SCHEMBL2902229

COc1ccc(-c2ccc(C(c3c[nH]nc3-c3ccco3)N3CCN(C(=O)O)CC3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A1 P00352 7/20 0.46
TSHR P16473 4/20 0.46
HTT P42858 2/20 0.46
KMT2A Q03164 4/20 0.46
MAPT P10636 3/20 0.46
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 2/20 0.46
NPC1 O15118 2/20 0.44
CACNA2D1 P54289 3/20 0.43
CACNB1 Q02641 3/20 0.43
CACNA1B Q00975 2/20 0.43
CACNA1C Q13936 2/20 0.43
CACNA1G O43497 1/20 0.43
LMNA P02545 4/20 0.41
USP2 O75604 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 2/20 0.41
RAB9A P51151 1/20 0.41
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2905980 0.89 ALDH1A1 (0.42) ALDH1A1TSHRMAPTKDM4ENPC1
SCHEMBL2908989 0.89 KMT2A (0.44) SMN1; SMN2ALDH1A1TSHRHTTKMT2A
SCHEMBL2905283 0.88 ALDH1A1 (0.52) ALDH1A1TSHRHTTKMT2AMAPT
SCHEMBL2905924 0.86 OPRD1 (0.40) SMN1; SMN2ALDH1A1TSHRHTTKMT2A
SCHEMBL2908995 0.86 BRAF (0.46) ALDH1A1TSHRHTTKMT2AMAPT
SCHEMBL2910374 0.85 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1TSHRHTTKMT2A
SCHEMBL2907051 0.84 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1TSHRHTTKMT2A
SCHEMBL2901677 0.82 MAPT (0.39) SMN1; SMN2ALDH1A1TSHRHTTKMT2A
SCHEMBL2902713 0.79 CYP3A4 (0.42) ALDH1A1TSHRMAPTKDM4ENPC1
SCHEMBL2908049 0.78 ALDH1A1 (0.46) ALDH1A1TSHRHTTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611107-B1 1,3,4-SUBSTITUTED PYRAZOLES FOR USE AS 5-HT RECEPTOR ANTAGONISTS IN THE TREATMENT OF PSYCHOSES AND NEUROLOGICAL DISORDERS MERCK PATENT GMBH (DE) 2010-08-18 EP claimed